Epstein-Barr virus (EBV) is
IntroductionEpstein-Barr virus (EBV) is a ubiquitous, potentially oncogenic human herpes virus affecting up to 95% of the adult population worldwide. Primary infection often occurs in childhood 1 as asymptomatic or mild self-limiting illness or as infectious mononucleosis in adults. 2 In immunocompromised patients with impaired cellmediated immunity, acute EBV infection is associated with the development of lymphoproliferative disease (LPD) with mortality rates between 10% and 100%. 3 In recipients of solid organ transplants, the incidence of posttransplant lymphoproliferative disease (PTLD) ranges from 1% to 15%, with the highest risk in EBV IgG-seronegative recipients receiving a graft from EBV IgG-seropositive donors. 4 Dendritic cells (DCs) are a rare, heterogenous population of antigen-presenting cells (APCs) that initiate and regulate both innate and adaptive immune responses against invading pathogens. [5][6][7] There are at least 2 circulating blood DC subsets including myeloid DC (MDCs) and plasmacytoid DC (PDCs). 8,9 Although both DC subsets are involved in the initial response against infectious agents, PDCs play a key role in antiviral immunity. PDC precursors (pre-PDCs) express distinct lymphoid markers including pre-T␣, 5, Ig1-like 14.1, and Spi-B; blood DC antigen 2 (BDCA-2) and BDCA-4 (neuropilin-1) 11 ; and toll-like receptor 7 (TLR-7) and TLR-9. 12,13 Viral stimulation of TLR-7 and TLR-9 expressed on PDCs results in production of type I interferons (IFNs), 12,13 key cytokines in antiviral response. 10,14,15 Humanized severe combined immunodeficiency (SCID) mice are a well-established model of spontaneous EBV-induced B-cell lymphoma. 16 Nonobese diabetic (NOD)-SCID mice possess additional immunologic defects (eg, decreased murine natural killer [NK] cell function) that permit greater engraftment of human cells following injection of human peripheral blood mononuclear cells (PBMCs). 17 In a previous study, we demonstrated that circulating pre-PDCs are severely reduced in the peripheral blood of renal transplant recipients resulting in impaired IFN-␣ production by PBMCs following viral stimulation. 18 We hypothesized that the reduction in circulating pre-PDCs observed in transplant recipients plays a crucial role in the risk of viral infection, and in particular EBV-related infection and the onset of LPD. In the present study, we address this hypothesis by assessing the impact of a reduction in the numbers of circulating PDCs in the development of EBVrelated infection and LPD using a humanized NOD-SCID mouse model as a surrogate model of human EBV infection. We demonstrate that reduction in PDCs enhances the development of EBV-related infection and LPD, whereas the supplementation of extra PDCs delays or even prevents the development of EBVrelated LPD in humanized NOD-SCID mice. We now show for the first time that PDCs are involved in anti-EBV immunity by the secretion of IFN-␣ and activation of T cells mediated by TLR-9 pathways. Thus, manipulating PDCs may provide no...